1. Regulation of apoptosis, autophagy and ferroptosis by non‑coding RNAs in metastatic non‑small cell lung cancer (Review)
   Lei Xu et al, 2022, Exp Ther Med CrossRef
2. Neoplastic signatures: Comparative proteomics of canine hepatobiliary neuroendocrine tumors to normal niche tissue
   Tifini L. Batts et al, 2023, PLoS ONE CrossRef
3. Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells
   Xiaojing Xing et al, 2023, Oncol Rep CrossRef
4. The pharmacological and biological importance of EZH2 signaling in lung cancer
   Maliheh Entezari et al, 2023, Biomedicine & Pharmacotherapy CrossRef
5. Astaxanthin inhibits integrin α5 expression by suppressing activation of JAK1/STAT3 in Helicobacter pylori‑stimulated gastric epithelial cells.
   Jieun Woo et al, 2023, Mol Med Rep CrossRef
6. Single-cell transcriptomics uncover hub genes and cell–cell crosstalk in patients with hypertensive nephropathy
   Rong Tang et al, 2023, International Immunopharmacology CrossRef
7. Mechanoregulation and function of calponin and transgelin
   Monica Rasmussen et al, 2024 CrossRef
8. Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors
   Arba Karcini et al, 2024, Front. Pharmacol. CrossRef
9. siRNA-based strategies to combat drug resistance in gastric cancer
   Abdulrahman Qais Khaleel et al, 2024, Med Oncol CrossRef
10. Development of a prognostic model incorporating a cuproptosis-related signature and CNN3 as a predictor in childhood acute myelocytic leukemia
    Jiafan Cao et al, 2024, Front. Oncol. CrossRef
11. The modulation of lung cancer cell motility by Calponin 3 is achieved through its ability to sense and respond to changes in substrate stiffness
    Yinxiu Chi et al, 2024, Biotech & Bioengineering CrossRef
12. Calponin 3 Regulates Myoblast Proliferation and Differentiation Through Actin Cytoskeleton Remodeling and YAP1-Mediated Signaling in Myoblasts
    Mai Thi Nguyen et al, 2025, Cells CrossRef